Biofil Chemicals

{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "37.35",
    "chg": 6.09,
    "chgp": "19.48%",
    "dir": 1,
    "prev_price": "31.26",
    "mcapval": "60.78 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE829A01014",
    "curr_date": "Sep 10, 02:55 PM",
    "curr_time": "14:56 PM",
    "last_traded_at": "Sep 10, 02:55 PM IST",
    "bse_nse_vol": "6.22 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 10, 2026",
    "traded_date_str": "2026 09 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 19.58% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4189562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BiofilChemicals_stocks_hitting_upper_circuit_4189562.png",
        "date": "2026-09-10 14:00:10",
        "description": "At Rs 37.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 19.58% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4159101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_mojoScore_4159101.png",
        "date": "2026-08-18 08:41:54",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating, reflecting deteriorating fundamentals and technical indicators. The downgrade, effective from 17 Aug 2026, is driven by a combination of worsening technical trends, stretched valuation metrics, flat financial performance, and weak quality scores, signalling caution for investors in this micro-cap pharmaceutical stock."
      },
      {
        "title": "Biofil Chemicals Gains 1.21%: Valuation Shifts and Technical Upgrades Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-gains-121-valuation-shifts-and-technical-upgrades-shape-the-week-4156051",
        "imagepath": "",
        "date": "2026-08-15 17:13:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opens at Rs.33.00, up 2.33%</p>\n                    <p><strong>11 Aug:</strong> Rating upgraded to Sell on technical improvements</p>\n                    <p><strong>12 Aug:</strong> Stock dips to Rs.32.41 amid valuation concerns</p>\n                    <p><strong>13 Aug:</strong> Valuation shifts signal price attractiveness decline</p>\n                    <p><strong>14 Aug:</strong> Week closes at Rs.32.64, up 1.49% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.32.25</div></div>\n                    <div class=\"stat-ite..."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-valuation-shifts-signal-price-attractiveness-decline-4150849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_valuationdot_4150849.png",
        "date": "2026-08-13 08:00:34",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from a previously very attractive position to now being classified as very expensive. This change is underscored by a surge in its price-to-earnings (P/E) ratio to 109.85 and a price-to-book value (P/BV) of 2.45, significantly outpacing both historical averages and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-upgraded-to-sell-on-technical-improvements-4149528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_mojoScore_4149528.png",
        "date": "2026-08-12 08:28:08",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental challenges. This nuanced change reflects a mildly improved technical outlook amid ongoing financial underperformance and valuation considerations within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-4134670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiofilChemicals_mojoScore_4134670.png",
        "date": "2026-08-04 10:11:02",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4114955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiofilChemicals_mojoScore_4114955.png",
        "date": "2026-07-22 10:11:29",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4096177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiofilChemicals_mojoScore_4096177.png",
        "date": "2026-07-10 10:11:09",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4076757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_mojoScore_4076757.png",
        "date": "2026-06-29 10:11:09",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 196,
    "sid": "386748",
    "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Aug-2026",
      "details": "Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) Free Press Indore (English) and Choutha Sansar (Hindi) edition.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Notice Of Convening 41St AGM Of The Company.",
      "datetime": "26-Aug-2026",
      "details": "Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)",
      "source": "BSE"
    },
    {
      "caption": "Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants",
      "datetime": "26-Aug-2026",
      "details": "Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 19.58% Gain — Buyers Queue, Sellers Absent

2026-09-10 14:00:10

At Rs 37.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 19.58% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Biofil Chemicals & Pharmaceuticals Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-08-18 08:41:54

Biofil Chemicals & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating, reflecting deteriorating fundamentals and technical indicators. The downgrade, effective from 17 Aug 2026, is driven by a combination of worsening technical trends, stretched valuation metrics, flat financial performance, and weak quality scores, signalling caution for investors in this micro-cap pharmaceutical stock.

Read full news article

Biofil Chemicals Gains 1.21%: Valuation Shifts and Technical Upgrades Shape the Week

2026-08-15 17:13:19

Key Events This Week

10 Aug: Stock opens at Rs.33.00, up 2.33%

11 Aug: Rating upgraded to Sell on technical improvements

12 Aug: Stock dips to Rs.32.41 amid valuation concerns

13 Aug: Valuation shifts signal price attractiveness decline

14 Aug: Week closes at Rs.32.64, up 1.49% on the day

Week Open

Rs.32.25

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Price Attractiveness Decline

2026-08-13 08:00:34

Biofil Chemicals & Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from a previously very attractive position to now being classified as very expensive. This change is underscored by a surge in its price-to-earnings (P/E) ratio to 109.85 and a price-to-book value (P/BV) of 2.45, significantly outpacing both historical averages and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements

2026-08-12 08:28:08

Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental challenges. This nuanced change reflects a mildly improved technical outlook amid ongoing financial underperformance and valuation considerations within the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell

2026-08-04 10:11:02

Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-07-22 10:11:29

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-07-10 10:11:09

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-06-29 10:11:09

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News